Cellapeutics

Category:
Main Business Area

“CELLACON® Platform – the technology of somatic cell reprogramming” is an integrated platform for innovative cell therapy technologies composed of “Cellapeutics Bio’s three major technologies of cella X, cella O, and cella M”.

Wishlist

Cellapeutics Bio is developing the popularization of cell therapy with innovative technology.
Based on the “CELLACON® Platform – the technology of somatic cell reprogramming”, the innovation that everyone enjoys, we develop therapy products for degenerative/ intractable diseases that cannot be fundamentally treated.
“CELLACON® Platform – the technology of somatic cell reprogramming” is a technology that converts patient’s somatic cells directly into differentiated cells for treatment and uses them as therapy products based on a small-molecule drug formula, which innovatively makes up for the shortcomings of existing cell therapy products.

Contact Details

#R3.59, INSTITUT PASTEUR KOREA, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do +82-31-8064-1800admin@cellapeutics.com

Find out more companies
Scroll to Top